First cell-based flu vaccine listed on NIP ahead of 2024 season
![](https://www.ausdoc.com.au/wp-content/uploads/2022/08/elderly20man20vaccination20iStock-1279370441-5.jpg)
A cell-based quadrivalent flu vaccine will be available on the National Immunisation Program for the first time this year for patients at higher risk of complications from influenza.
From 1 March, Aboriginal and Torres Strait Islander people aged 5-64; pregnant women; and patients aged 5-64 with co-existing conditions, including diabetes, chronic renal failure, heart disease and chronic respiratory or neurological conditions, can get CSL Seqirus’ Flucelvax Quad for free.